251 related articles for article (PubMed ID: 26890637)
1. Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.
Mittra ES; Koglin N; Mosci C; Kumar M; Hoehne A; Keu KV; Iagaru AH; Mueller A; Berndt M; Bullich S; Friebe M; Schmitt-Willich H; Gekeler V; Fels LM; Bacher-Stier C; Moon DH; Chin FT; Stephens AW; Dinkelborg LM; Gambhir SS
PLoS One; 2016; 11(2):e0148628. PubMed ID: 26890637
[TBL] [Abstract][Full Text] [Related]
2.
Wardak M; Sonni I; Fan AP; Minamimoto R; Jamali M; Hatami N; Zaharchuk G; Fischbein N; Nagpal S; Li G; Koglin N; Berndt M; Bullich S; Stephens AW; Dinkelborg LM; Abel T; Manning HC; Rosenberg J; Chin FT; Gambhir SS; Mittra ES
Radiology; 2022 Jun; 303(3):620-631. PubMed ID: 35191738
[TBL] [Abstract][Full Text] [Related]
3. (4S)-4-(3-18F-fluoropropyl)-L-glutamate for imaging of xC transporter activity in hepatocellular carcinoma using PET: preclinical and exploratory clinical studies.
Baek S; Mueller A; Lim YS; Lee HC; Lee YJ; Gong G; Kim JS; Ryu JS; Oh SJ; Lee SJ; Bacher-Stier C; Fels L; Koglin N; Schatz CA; Dinkelborg LM; Moon DH
J Nucl Med; 2013 Jan; 54(1):117-23. PubMed ID: 23232273
[TBL] [Abstract][Full Text] [Related]
4. Initial evaluation of (4S)-4-(3-[
Park SY; Mosci C; Kumar M; Wardak M; Koglin N; Bullich S; Mueller A; Berndt M; Stephens AW; Chin FT; Gambhir SS; Mittra ES
EJNMMI Res; 2020 Aug; 10(1):100. PubMed ID: 32857284
[TBL] [Abstract][Full Text] [Related]
5. Comparative Evaluation of [
Colovic M; Yang H; Southcott L; Merkens H; Colpo N; Bénard F; Schaffer P
J Nucl Med; 2023 Aug; 64(8):1314-1321. PubMed ID: 37116917
[TBL] [Abstract][Full Text] [Related]
6. Prospective comparison of (4S)-4-(3-
Cheng MF; Huang YY; Ho BY; Kuo TC; Hsin LW; Shiue CY; Kuo HC; Jeng YM; Yen RF; Tien YW
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):810-820. PubMed ID: 30635754
[TBL] [Abstract][Full Text] [Related]
7. Utility of [
Kavanaugh G; Williams J; Morris AS; Nickels ML; Walker R; Koglin N; Stephens AW; Washington MK; Geevarghese SK; Liu Q; Ayers D; Shyr Y; Manning HC
Mol Imaging Biol; 2016 Dec; 18(6):924-934. PubMed ID: 27677886
[TBL] [Abstract][Full Text] [Related]
8. 18F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules.
Paez R; Shah C; Cords AJ; Muterspaugh A; Helton JE; Antic S; Eisenberg R; Chen H; Grogan EL; Manning HC; Walker RC; Massion PP
PLoS One; 2022; 17(3):e0265427. PubMed ID: 35294486
[TBL] [Abstract][Full Text] [Related]
9. Exploratory clinical trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate for imaging xC- transporter using positron emission tomography in patients with non-small cell lung or breast cancer.
Baek S; Choi CM; Ahn SH; Lee JW; Gong G; Ryu JS; Oh SJ; Bacher-Stier C; Fels L; Koglin N; Hultsch C; Schatz CA; Dinkelborg LM; Mittra ES; Gambhir SS; Moon DH
Clin Cancer Res; 2012 Oct; 18(19):5427-37. PubMed ID: 22893629
[TBL] [Abstract][Full Text] [Related]
10. Radiotracer stereochemistry affects substrate affinity and kinetics for improved imaging of system x
Greenwood HE; Edwards R; Koglin N; Berndt M; Baark F; Kim J; Firth G; Khalil E; Mueller A; Witney TH
Theranostics; 2022; 12(4):1921-1936. PubMed ID: 35198080
[TBL] [Abstract][Full Text] [Related]
11. [
Hoehne A; James ML; Alam IS; Ronald JA; Schneider B; D'Souza A; Witney TH; Andrews LE; Cropper HC; Behera D; Gowrishankar G; Ding Z; Wyss-Coray T; Chin FT; Biswal S; Gambhir SS
J Neuroinflammation; 2018 Feb; 15(1):55. PubMed ID: 29471880
[TBL] [Abstract][Full Text] [Related]
12. (S)-4-(3-18F-fluoropropyl)-L-glutamic acid: an 18F-labeled tumor-specific probe for PET/CT imaging--dosimetry.
Smolarz K; Krause BJ; Graner FP; Wagner FM; Hultsch C; Bacher-Stier C; Sparks RB; Ramsay S; Fels LM; Dinkelborg LM; Schwaiger M
J Nucl Med; 2013 Jun; 54(6):861-6. PubMed ID: 23568366
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Physiologic (18)F FSPG Uptake in Healthy Volunteers.
Mosci C; Kumar M; Smolarz K; Koglin N; Stephens AW; Schwaiger M; Gambhir SS; Mittra ES
Radiology; 2016 Jun; 279(3):898-905. PubMed ID: 26785040
[TBL] [Abstract][Full Text] [Related]
14. Clinical Evaluation of (4S)-4-(3-[
Park SY; Na SJ; Kumar M; Mosci C; Wardak M; Koglin N; Bullich S; Mueller A; Berndt M; Stephens AW; Cho YM; Ahn H; Chae SY; Kim HO; Moon DH; Gambhir SS; Mittra ES
Clin Cancer Res; 2020 Oct; 26(20):5380-5387. PubMed ID: 32694158
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
[TBL] [Abstract][Full Text] [Related]
16. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
Cai L; Gao S; Li DC; Li YS; Chen QS; Xing XL
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):134-8. PubMed ID: 19538892
[TBL] [Abstract][Full Text] [Related]
17. 18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer.
Pauleit D; Zimmermann A; Stoffels G; Bauer D; Risse J; Flüss MO; Hamacher K; Coenen HH; Langen KJ
J Nucl Med; 2006 Feb; 47(2):256-61. PubMed ID: 16455631
[TBL] [Abstract][Full Text] [Related]
18. 18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas.
Sai KK; Huang C; Yuan L; Zhou D; Piwnica-Worms D; Garbow JR; Engelbach JA; Mach RH; Rich KM; McConathy J
J Nucl Med; 2013 Jul; 54(7):1120-6. PubMed ID: 23650628
[TBL] [Abstract][Full Text] [Related]
19. Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.
Pauleit D; Stoffels G; Bachofner A; Floeth FW; Sabel M; Herzog H; Tellmann L; Jansen P; Reifenberger G; Hamacher K; Coenen HH; Langen KJ
Nucl Med Biol; 2009 Oct; 36(7):779-87. PubMed ID: 19720290
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
